Shares of Moderna jumped by a staggering 17.73% to $128.54 at 11:07 EST on Friday, following yesterday’s upward trend. The Nasdaq Stock Market is jumping 1.07% to $12,224.10, after three successive sessions in a row of gains, on what so far seems, an all-around positive trend trading session today.
Moderna’s last close was $109.18, 3.71% under its 52-week high of $123.94.
Moderna’s sales growth is 1425.2% for the present quarter and 9666.5% for the next. The company’s growth estimates for the present quarter is a negative 48.6% and positive 437.1% for the next.
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s stock is valued at $128.54 at 11:07 EST, higher than its 52-week high of $123.94.
Moderna’s worth is way above its 50-day moving average of $79.01 and way higher than its 200-day moving average of $70.45.
According to Bloomberg Quint on Mon Nov 23, “Moderna Chief Sells More Shares Ahead of Urgent Vaccine Filing.”
According to Bloomberg Quint on Wed Nov 25, “Moderna Soars to Record Ahead of Final Covid Vaccine Analysis.”